SEC Form 4 · accession 0001867426-26-000004
PLIANT THERAPEUTICS, INC. · PLRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Flavia Borellini
Director
Period of report
Jul 9, 2026
Accepted (ET)
Jul 13, 2026 · 4:32 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001746473
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1.13 | Jul 9, 2026 | A | 60,000 | A | — | Jul 9, 2036 | Common Stock | 60,000 | 60,000 | D |
Explanation of responses
- F11/36th of the shares subject to such option vest and become exercisable in substantially equal installments on each monthly anniversary of July 9, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date.